Distinct Conformational Dynamics of Three G Protein-Coupled Receptors Measured Using FlAsH-BRET Biosensors

A number of studies have profiled G protein-coupled receptor (GPCR) conformation using fluorescent biaresenical hairpin binders (FlAsH) as acceptors for BRET or FRET. These conformation-sensitive biosensors allow reporting of movements occurring on the intracellular surface of a receptor to investigate mechanisms of receptor activation and function. Here, we generated eight FlAsH-BRET-based biosensors within the sequence of the β2-adrenergic receptor (β2AR) and compared agonist-induced responses to the angiotensin II receptor type I (AT1R) and the prostaglandin F2α receptor (FP). Although all three receptors had FlAsH-binding sequences engineered into the third intracellular loops and carboxyl-terminal domain, both the magnitude and kinetics of the BRET responses to ligand were receptor-specific. Biosensors in ICL3 of both the AT1R and FP responded robustly when stimulated with their respective full agonists as opposed to the β2AR where responses in the third intracellular loop were weak and transient when engaged by isoproterenol. C-tail sensors responses were more robust in the β2AR and AT1R but not in FP. Even though GPCRs share the heptahelical topology and are expressed in the same cellular background, different receptors have unique conformational fingerprints.

[1]  D. Devost,et al.  Conformational Profiling of the AT1 Angiotensin II Receptor Reflects Biased Agonism, G Protein Coupling, and Cellular Context* , 2017, The Journal of Biological Chemistry.

[2]  M. Zimmer,et al.  Activation of the A2A adenosine G-protein-coupled receptor by conformational selection , 2016, Nature.

[3]  T. S. Kobilka,et al.  Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling , 2015, Cell.

[4]  Sébastien Boutet,et al.  Structure of the Angiotensin Receptor Revealed by Serial Femtosecond Crystallography , 2015, Cell.

[5]  Joachim Goedhart,et al.  Fourth-Generation Epac-Based FRET Sensors for cAMP Feature Exceptional Brightness, Photostability and Dynamic Range: Characterization of Dedicated Sensors for FLIM, for Ratiometry and with High Affinity , 2015, PloS one.

[6]  María Martín,et al.  UniProt: A hub for protein information , 2015 .

[7]  Yang Zhang,et al.  The I-TASSER Suite: protein structure and function prediction , 2014, Nature Methods.

[8]  D. Devost,et al.  Angiotensin II Type I and Prostaglandin F2α Receptors Cooperatively Modulate Signaling in Vascular Smooth Muscle Cells* , 2014, The Journal of Biological Chemistry.

[9]  The Uniprot Consortium,et al.  UniProt: a hub for protein information , 2014, Nucleic Acids Res..

[10]  Albert C. Pan,et al.  The Dynamic Process of β2-Adrenergic Receptor Activation , 2013, Cell.

[11]  T. Hébert,et al.  D2-like dopamine and β-adrenergic receptors form a signaling complex that integrates Gs- and Gi-mediated regulation of adenylyl cyclase. , 2012, Cellular signalling.

[12]  S. Nuber,et al.  Fluorescence/Bioluminescence Resonance Energy Transfer Techniques to Study G-Protein-Coupled Receptor Activation and Signaling , 2012, Pharmacological Reviews.

[13]  Krzysztof Palczewski,et al.  The Significance of G Protein-Coupled Receptor Crystallography for Drug Discovery , 2011, Pharmacological Reviews.

[14]  S. Rasmussen,et al.  Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.

[15]  U. Zabel,et al.  FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors. , 2011, Bioorganic & medicinal chemistry.

[16]  Martin J. Lohse,et al.  Sensing G protein-coupled receptor activation , 2011, Neuropharmacology.

[17]  M. Lohse,et al.  Differential Signaling of the Endogenous Agonists at the β2-Adrenergic Receptor* , 2010, The Journal of Biological Chemistry.

[18]  M. Lohse,et al.  A Fluorescence Resonance Energy Transfer-based M2 Muscarinic Receptor Sensor Reveals Rapid Kinetics of Allosteric Modulation* , 2010, Journal of Biological Chemistry.

[19]  M. Bouvier,et al.  Distinct Signaling Profiles of β1 and β2 Adrenergic Receptor Ligands toward Adenylyl Cyclase and Mitogen-Activated Protein Kinase Reveals the Pluridimensionality of Efficacy , 2006, Molecular Pharmacology.

[20]  M. Maeda,et al.  FRET-based monitoring of conformational change of the beta2 adrenergic receptor in living cells. , 2006, Biochemical and biophysical research communications.

[21]  Olivier Lichtarge,et al.  β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor* , 2006, Journal of Biological Chemistry.

[22]  Jean-François Mercier,et al.  Homodimerization of the β2-Adrenergic Receptor as a Prerequisite for Cell Surface Targeting* , 2004, Journal of Biological Chemistry.

[23]  M. Bouvier,et al.  Roles of G‐protein‐coupled receptor dimerization , 2004, EMBO reports.

[24]  G. Milligan Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. , 2003, Molecular pharmacology.

[25]  H. Schiöth,et al.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.

[26]  M. Bouvier,et al.  Biochemical Characterization of β2-Adrenergic Receptor Dimers and Oligomers , 2003, Biological chemistry.

[27]  E. Lakatta,et al.  β1/β2-Adrenergic Receptor Heterodimerization Regulates β2-Adrenergic Receptor Internalization and ERK Signaling Efficacy* , 2002, The Journal of Biological Chemistry.

[28]  Robert E Campbell,et al.  New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications. , 2002, Journal of the American Chemical Society.

[29]  H. Lother,et al.  The Angiotensin II AT2 Receptor Is an AT1Receptor Antagonist* , 2001, The Journal of Biological Chemistry.

[30]  R. Xiao β-Adrenergic Signaling in the Heart: Dual Coupling of the β2-Adrenergic Receptor to Gs and Gi Proteins , 2001, Science's STKE.

[31]  J. Gutkind,et al.  G-protein-coupled receptors and signaling networks: emerging paradigms. , 2001, Trends in pharmacological sciences.

[32]  W. White,et al.  &bgr;2-Adrenergic and Several Other G Protein–Coupled Receptors in Human Atrial Membranes Activate Both Gs and Gi , 2000 .

[33]  H. Lother,et al.  AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration , 2000, Nature.

[34]  R Y Tsien,et al.  Specific covalent labeling of recombinant protein molecules inside live cells. , 1998, Science.

[35]  Robert J. Lefkowitz,et al.  Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A , 1997, Nature.

[36]  Michel Bouvier,et al.  A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.

[37]  Ryan T. Strachan,et al.  reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation. , 2016 .

[38]  D. Devost,et al.  Designing BRET-based conformational biosensors for G protein-coupled receptors. , 2016, Methods.

[39]  P. Greengard,et al.  Bioluminescence resonance energy transfer methods to study G protein-coupled receptor-receptor tyrosine kinase heteroreceptor complexes. , 2013, Methods in cell biology.